Literature DB >> 16341121

High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.

G M Pierantoni1, C Rinaldo, F Esposito, M Mottolese, S Soddu, A Fusco.   

Abstract

HMGA gene overexpression and rearrangements are frequent in several tumours, but their oncogenic function is still unclear. Here we report of a physical and functional interaction between High Mobility Group A1 (HMGA1) protein and p53 oncosuppressor. We found that HMGA1 binds p53 in vitro and in vivo, and both proteins are present in the same complexes bound to the Bax gene promoter. HMGA1 interferes with the p53-mediated transcription of p53 effectors Bax and p21(waf1) while cooperates with p53 in the transcriptional activation of the p53 inhibitor mdm2. This transcriptional modulation is associated with a reduced p53-dependent apoptosis in cells expressing exogenous HMGA1 and p53, or in cells expressing endogenously the proteins and in which p53 was activated by UV-irradiation. Furthermore, antisense inhibition of HMGA1b expression dramatically increases the UV-induced p53-mediated apoptosis. These data define a new physical and functional interaction between HMGA1 and p53 that modulates transcription of p53 target genes and inhibits apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341121     DOI: 10.1038/sj.cdd.4401839

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  28 in total

Review 1.  HMG chromosomal proteins in development and disease.

Authors:  Robert Hock; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  Trends Cell Biol       Date:  2006-12-13       Impact factor: 20.808

2.  Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.

Authors:  Kristen A Wieghaus; Erwin P Gianchandani; Milton L Brown; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng       Date:  2007-10

3.  A TSH-CREB1-microRNA loop is required for thyroid cell growth.

Authors:  Vincenza Leone; Daniela D'Angelo; Angelo Ferraro; Pierlorenzo Pallante; Ileana Rubio; Massimo Santoro; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 4.  High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

Authors:  S S Liau; E Whang
Journal:  Surgeon       Date:  2009-10       Impact factor: 2.392

5.  CBX7 is a tumor suppressor in mice and humans.

Authors:  Floriana Forzati; Antonella Federico; Pierlorenzo Pallante; Adele Abbate; Francesco Esposito; Umberto Malapelle; Romina Sepe; Giuseppe Palma; Giancarlo Troncone; Marzia Scarfò; Claudio Arra; Monica Fedele; Alfredo Fusco
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

6.  HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.

Authors:  Miki Watanabe; Sulaiman Sheriff; Kenneth B Lewis; Stuart L Tinch; Junho Cho; Ambikaipakan Balasubramaniam; Michael A Kennedy
Journal:  Cancer Lett       Date:  2011-10-10       Impact factor: 8.679

7.  High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.

Authors:  Yunzhi Zhang; Teng Ma; Shuping Yang; Mingying Xia; Jing Xu; Haijia An; Yajun Yang; Shilin Li
Journal:  Mol Cell Biochem       Date:  2011-06-09       Impact factor: 3.396

8.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

9.  Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.

Authors:  X-B Shi; L Xue; A-H Ma; C G Tepper; R Gandour-Edwards; H-J Kung; R W deVere White
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

10.  Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.

Authors:  Massimiliano Mellone; Christian Rinaldi; Isabella Massimi; Marialaura Petroni; Veronica Veschi; Claudio Talora; Silvia Truffa; Helena Stabile; Luigi Frati; Isabella Screpanti; Alberto Gulino; Giuseppe Giannini
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.